ArticleBMC nephrology2023

Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case series.

Lin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.